Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-01-19
1994-03-01
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514512, 514513, 514533, 514535, 514538, 514486, 514833, 548403, 548478, 548416, 548473, 560 30, 560 31, 560 32, 568452, 568455, A61K 3140, A61K 31325, C07C 4500
Patent
active
052908038
ABSTRACT:
A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The compounds are capable of acting on hemoglobin in whole blood. In addition, the compounds can maintain the oxygen affinity in blood during storage and can restore the oxygen affinity of outdated blood.
REFERENCES:
patent: 5122539 (1992-06-01), Abraham et al.
Abraham Donald J.
Mahran Mona
Mehanna Ahmed
Randad Ramnarayan
Dees Jos,e G.
Nazario-Gonzalez Porfirio
The Center of Innovative Technology
LandOfFree
Using allosteric hemoglobin modifiers to decrease oxygen affinit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Using allosteric hemoglobin modifiers to decrease oxygen affinit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Using allosteric hemoglobin modifiers to decrease oxygen affinit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-577468